Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

DGAP Post-admission Duties announcement: Fresenius Medical Care AG & Co. KGaA / Announcement pursuant to Art. 5 para. 1 lit. b), para. 3 of Regulation (EU) No 596/2014 and Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 Fresenius Medical Care AG & Co. KGaA: Release of a capital market information 03.04.2020 / 10:10 Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. - Share buy-back - 42nd Interim Report and Final Report In the period from March 30, 2020 until and including April 1, 2020, a total of 1,906,796 shares were repurchased within the framework of the share buy-back programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius Medical Care') announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052. The purchase was carried out exclusively by a credit institution commissioned by Fresenius Medical Care via the XETRA trading platform on the Frankfurt Stock Exchange and via selected multilateral trading facilities (MTF): XETRA Day of repurchase Aggregated volume in number of shares Weighted average share price in EUR 30.03.2020 507,449 58.1217 31.03.2020 498,159 59.7579 01.04.2020 538,530 59.3516   Chi-X Europe Day of repurchase Aggregated volume in number of shares Weighted average share price in EUR 30.03.2020 78,533 58.1681 31.03.2020 71,899 59.7985 01.04.2020 99,953 59.3799   BATS Europe Day of repurchase Aggregated volume in number of shares Weighted average share price in EUR 30.03.2020 11,516 58.2242 31.03.2020 19,031 59.7440 01.04.2020 31,370 59.4862   Turquoise Day of repurchase Aggregated volume in number of shares Weighted average share price in EUR 30.03.2020 13,694 58.0568 31.03.2020 11,702 59.6980 01.04.2020 24,960 59.2190   The total volume of shares repurchased within the framework of this share buy-back in the period from June 17, 2019 until and including April 1, 2020 therefore amounts to 10,795,151 shares. The weighted average share price paid for these shares amounted to EUR 61.0270. This concludes the share buy-back programme. Detailed information on the transactions pursuant to Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical Care's website at www.freseniusmedicalcare.com under section Investors. Fresenius Medical Care AG & Co. KGaA represented by Fresenius Medical Care Management AG represented by its Management Board Bad Homburg v.d.H., April 3, 2020 03.04.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language:	English
Company:	Fresenius Medical Care AG & Co. KGaA
	Else-Kröner-Straße 1
	61352 Bad Homburg
	Germany
Internet:	www.freseniusmedicalcare.com

End of News	DGAP News Service

1014831  03.04.2020